SUCNR1 inhibitors (Novartis Institutes for BioMedical Research)

N/A

Report date: 2025/01/26 17:17:11
NME

Base Information

Drug NameSUCNR1 inhibitors (Novartis Institutes for BioMedical Research)
Drug Alias NameGPR91 inhibitors (Novartis Institutes for BioMedical Research)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuccinate receptor 1 inhibitors
TargetsSuccinate receptor 1
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Institutes For Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Institutes For Biomedical Research Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A